Laseroptek Co., Ltd.
Laseroptek Co., Ltd. develops and manufactures aesthetic and medical laser devices in South Korea. Its laser devices perform aesthetic and medical dermatological treatments for a range of indications, such as benign pigmentation lesions, fine lines and wrinkles, scar revision, skin rejuvenation and lifting, hair removal, vascular lesions, vitiligo, psoriasis, atopic dermatitis, leukoderma, and al… Read more
Laseroptek Co., Ltd. (199550) - Total Assets
Latest total assets as of September 2024: ₩45.30 Billion KRW
Based on the latest financial reports, Laseroptek Co., Ltd. (199550) holds total assets worth ₩45.30 Billion KRW as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Laseroptek Co., Ltd. - Total Assets Trend (2020–2022)
This chart illustrates how Laseroptek Co., Ltd.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Laseroptek Co., Ltd. - Asset Composition Analysis
Current Asset Composition (December 2022)
Laseroptek Co., Ltd.'s total assets of ₩45.30 Billion consist of 66.5% current assets and 33.5% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩3.48 Billion | 0.0% |
| Accounts Receivable | ₩6.06 Billion | 24.1% |
| Inventory | ₩6.18 Billion | 24.5% |
| Property, Plant & Equipment | ₩5.56 Billion | 22.1% |
| Intangible Assets | ₩658.98 Million | 2.6% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2020–2022)
This chart illustrates how Laseroptek Co., Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Laseroptek Co., Ltd.'s current assets represent 66.5% of total assets in 2022, a decrease from 73.7% in 2020.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2022, the same as 0.0% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2020.
- Asset Diversification: The largest asset category is inventory at 24.5% of total assets.
Laseroptek Co., Ltd. Competitors by Total Assets
Key competitors of Laseroptek Co., Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Laseroptek Co., Ltd. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Laseroptek Co., Ltd. generates 1.19x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Laseroptek Co., Ltd. generates $ 11.18 in net profit.
Laseroptek Co., Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.21 | 2.64 | 2.64 |
| Quick Ratio | 2.38 | 2.06 | 2.06 |
| Cash Ratio | 0.04 | 0.01 | 0.01 |
| Working Capital | ₩23.89 Billion | ₩ 21.47 Billion | ₩ 21.47 Billion |
Laseroptek Co., Ltd. - Advanced Valuation Insights
This section examines the relationship between Laseroptek Co., Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.39 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 28.0% |
| Total Assets | ₩25.19 Billion |
| Market Capitalization | $21.68 Million USD |
Valuation Analysis
Below Book Valuation: The market values Laseroptek Co., Ltd.'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Laseroptek Co., Ltd.'s assets grew by 28.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Laseroptek Co., Ltd. (2020–2022)
The table below shows the annual total assets of Laseroptek Co., Ltd. from 2020 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | ₩25.19 Billion | +28.04% |
| 2021-12-31 | ₩19.67 Billion | +0.88% |
| 2020-12-31 | ₩19.50 Billion | -- |